BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27707960)

  • 1. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.
    Zlebnik NE; Cheer JF
    J Neurosci; 2016 Oct; 36(40):10230-10238. PubMed ID: 27707960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic functions of endocannabinoid signaling in health and disease.
    Araque A; Castillo PE; Manzoni OJ; Tonini R
    Neuropharmacology; 2017 Sep; 124():13-24. PubMed ID: 28625718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.
    Mato S; Chevaleyre V; Robbe D; Pazos A; Castillo PE; Manzoni OJ
    Nat Neurosci; 2004 Jun; 7(6):585-6. PubMed ID: 15146190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid signalling in reward and addiction.
    Parsons LH; Hurd YL
    Nat Rev Neurosci; 2015 Oct; 16(10):579-94. PubMed ID: 26373473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.
    Sidhpura N; Parsons LH
    Neuropharmacology; 2011 Dec; 61(7):1070-87. PubMed ID: 21669214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid-mediated synaptic plasticity and substance use disorders.
    Fernández-Espejo E; Núñez-Domínguez L
    Neurologia (Engl Ed); 2022; 37(6):459-465. PubMed ID: 30857785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress.
    Wang W; Sun D; Pan B; Roberts CJ; Sun X; Hillard CJ; Liu QS
    Neuropsychopharmacology; 2010 Oct; 35(11):2249-61. PubMed ID: 20664582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid-mediated synaptic plasticity and substance use disorders.
    Fernández-Espejo E; Núñez-Domínguez L
    Neurologia (Engl Ed); 2022; 37(6):459-465. PubMed ID: 34538595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function.
    Sagheddu C; Muntoni AL; Pistis M; Melis M
    Int Rev Neurobiol; 2015; 125():257-302. PubMed ID: 26638769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid mediator endocannabinoids in modulating synaptic transmission].
    Hashimotodani Y; Tanimura A; Kano M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):105-9. PubMed ID: 21800700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System.
    Augustin SM; Lovinger DM
    ACS Chem Neurosci; 2018 Sep; 9(9):2146-2161. PubMed ID: 29400439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine self-administration abolishes endocannabinoid-mediated long-term depression of glutamatergic synapses in the ventral tegmental area.
    Wang R; Hausknecht KA; Gancarz-Kausch AM; Oubraim S; Shen RY; Haj-Dahmane S
    Eur J Neurosci; 2020 Dec; 52(11):4517-4524. PubMed ID: 32959420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.
    Robbe D; Kopf M; Remaury A; Bockaert J; Manzoni OJ
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8384-8. PubMed ID: 12060781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of endocannabinoid control of synaptic plasticity.
    Winters BL; Vaughan CW
    Neuropharmacology; 2021 Oct; 197():108736. PubMed ID: 34343612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic plasticity in drug reward circuitry.
    Winder DG; Egli RE; Schramm NL; Matthews RT
    Curr Mol Med; 2002 Nov; 2(7):667-76. PubMed ID: 12420805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).
    Diana MA; Marty A
    Br J Pharmacol; 2004 May; 142(1):9-19. PubMed ID: 15100161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons.
    Zhong P; Liu Y; Hu Y; Wang T; Zhao YP; Liu QS
    J Neurosci; 2015 Mar; 35(10):4469-81. PubMed ID: 25762688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lights on Endocannabinoid-Mediated Synaptic Potentiation.
    Piette C; Cui Y; Gervasi N; Venance L
    Front Mol Neurosci; 2020; 13():132. PubMed ID: 32848597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CB1 receptors in psychostimulant addiction.
    Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
    Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.